Refine my results

Exposing concerns about vaccination in low- and middle-income countries: a systematic review

Cobos Muñoz, Daniel ; Monzón Llamas, Laura ; Bosch-Capblanch, Xavier

In: International Journal of Public Health, 2015, vol. 60, no. 7, p. 767-780

Herpes zoster vaccine: a shot to maintain wellbeing

Michel, Jean-Pierre

In: Aging Clinical and Experimental Research, 2015, vol. 27, no. 1, p. 1-3

Wie wirken sich Informationen zur HPV-Impfung auf den Impfentscheid junger Frauen aus? = What impact does information about the HPV vaccination have on the decision of young women to be vaccinated?

Zeyer, Albert ; Sidler, Tanja

Associations between key intervention coverage and child mortality: an analysis of 241 sub-national regions of sub-Saharan Africa

Akachi, Yoko ; Steenland, Maria ; Fink, Günther

In: International Journal of Epidemiology, 2018, vol. 47, no. 3, p. 740-751

The patent buyout price for human papilloma virus (HPV) vaccine and the ratio of R&D costs to the patent value

Songane, Mario ; Grossmann, Volker

In: PLOS One, 2021, p. 1-22

Human papillomavirus (HPV) is responsible for almost all of the 570,000 new cases of cervical cancer and approximately 311,000 deaths per year. HPV vaccination is an integral component of the World Health Organization’s (WHO) global strategy to fight the disease. However, high vaccine prices enforced through patent protection are limiting vaccine expansion, particularly in low- and...

Collaborating with complementary and alternative medicine (CAM) providers when writing HPV vaccine review articles

Deml, Michael J. ; Dietrich, Léna G. ; Wingeier, Bernhard ; Etter, Gisela ; Gallmann, Caesar ; Berger, Christoph ; Suggs, L. Suzanne ; Huber, Benedikt M. ; Tarr, Philip E.

In: Journal of clinical medicine, 2020, vol. 9, no. 2, p. 15 p

Novel strategies are needed to address vaccine hesitancy (VH), which correlates with complementary and alternative medicine (CAM). In Switzerland, CAM providers play important roles in vaccine counseling of vaccine hesitant (VH) parents, and traditional vaccination messaging tends to overlook CAM provider perspectives. In the setting of a Swiss national research program on VH, our key strategy ...

The patent buyout price for Human Papilloma Virus (HPV) vaccine and the ratio of R&D costs to the patent value

Songane, Mario ; Grossmann, Volker

(Working Papers SES ; 510)

Human papillomavirus (HPV) is responsible for almost all of the 530,000 new cases of cervical cancer and approximately 266,000 deaths per year. HPV vaccination is an integral component of the World Health Organization’s global strategy to fight the disease. However, high vaccine prices enforced through patent protection are limiting vaccine expansion, particularly in low- and middle-income...

Can Routine Offering of Influenza Vaccination in Office-Based Settings Reduce Racial and Ethnic Disparities in Adult Influenza Vaccination?

Maurer, Jürgen ; Harris, Katherine ; Uscher-Pines, Lori

In: Journal of General Internal Medicine, 2014, vol. 29, no. 12, p. 1624-1630

The impact of smoking on HPV infection and the development of anogenital warts

Kaderli, Reto ; Schnüriger, Beat ; Brügger, Lukas

In: International Journal of Colorectal Disease, 2014, vol. 29, no. 8, p. 899-908

Disparities in influenza vaccination coverage rates by target group in five European countries: Trends over seven consecutive seasons

Blank, P. ; Schwenkglenks, M. ; Szucs, T.

In: Infection, 2009, vol. 37, no. 5, p. 390-400